News
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
See previous years below:<br/><a href=" Reports in Cardiovascular Imaging: 2022<br/><a href=" Reports in Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback